Your Gateway to World-Class Healthcare in India
Advanced multiple myeloma care with latest targeted therapies, stem cell transplantation, and comprehensive treatment protocols by expert hematologists.
Multiple myeloma is a cancer of plasma cells in the bone marrow. India offers comprehensive treatment with the latest targeted therapies, immunotherapy, and stem cell transplantation at world-class facilities with significant cost advantages.
Our hematology centers provide personalized treatment plans using modern drug combinations, transplantation, and maintenance therapy. With access to CAR T-cell therapy and clinical trials, patients receive cutting-edge care.
Duration: 3-4 months
Goal: Achieve maximum response before transplant
Duration: 1-2 months
Goal: Eliminate remaining cancer cells
Duration: 2-3 years
Goal: Prevent disease recurrence
$350,000
Average treatment cost
$200,000
Average treatment cost
$250,000
Average treatment cost
$30,000
Save 75%!
A. With modern treatments, the 5-year survival rate is 50-60%, and many patients live 10+ years. Early-stage disease has even better outcomes.
A. Autologous stem cell transplant is standard for eligible patients under 70. It significantly improves outcomes and extends remission periods.
A. Initial treatment takes 6-8 months including transplant. Maintenance therapy continues for 2-3 years or until progression.
A. India offers all modern therapies including CAR T-cell therapy, bispecific antibodies, and access to international clinical trials.
Get personalized treatment information and cost estimates